20 ML sodium acetate 2 MEQ/ML Injection — RxCUI 1859490
RxNorm drug concept · Semantic clinical drug
RxCUI 1859490
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1859490
Official name20 ML sodium acetate 2 MEQ/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium acetate 40 MEQ per 20 ML Injection; sodium acetate 40 MEQ in 20 ML Injection
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)1,709 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sodium Acetate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's used in a hospital or clinical setting to raise sodium levels in patients whose sodium has dropped too low — a condition called hyponatremia. This usually happens when someone...
- What is Sodium Acetate Injection actually used for?
- Neither, exactly. It's given through an IV line directly into a vein, but only after it's been carefully diluted by pharmacy staff into a larger bag of IV fluid. It's never injecte...
- How is this medication given — do I swallow it or get a shot?
🕸️ Concept Web — How 20 ML sodium acetate 2 MEQ/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
20 ML sodium acetate 2 MEQ/ML Injection
RxCUI 1859490 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sodium acetate
56443IN
-
Sodium acetate
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sodium acetate Injection
1859489SCDF -
Sodium acetate Injectable Product
1158767SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Sodium acetate Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sodium acetate 2 MEQ/ML
316677SCDC
-
Sodium acetate 2 MEQ/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sodium acetate 2 MEQ/ML
SCDC · 316677 -
Sodium acetate Injection
SCDF · 1859489 -
Sodium acetate Injectable Product
SCDG · 1158767
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 1859490 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-7299-25 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7299-25) / 20 mL in 1... | Sodium Acetate | Hospira, Inc. | 2014-03-05 |
| 00409-7299-73 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7299-73) / 20 mL in 1... | Sodium Acetate | Hospira, Inc. | 2005-03-31 |
| 00641-6261-01 | 1 VIAL in 1 CARTON (0641-6261-01) / 20 mL in 1 VIAL | Sodium Acetate | Hikma Pharmaceuticals USA Inc. | 2024-05-20 |
| 71357-0002-10 | 10 VIAL, SINGLE-DOSE in 1 CASE (71357-002-10) / 20 mL in 1... | Sodium Acetate | MILLA PHARMACEUTICALS INC. | 2025-01-17 |
Observed labelers:
Hospira, Inc. (2) ·
Hikma Pharmaceuticals USA Inc. (1) ·
MILLA PHARMACEUTICALS INC. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.